🇺🇸 FDA
Pipeline program

ABP-450

ABP-19002

Phase 2 small_molecule completed

Quick answer

ABP-450 for Cervical Dystonia is a Phase 2 program (small_molecule) at AEON Biopharma with 2 ClinicalTrials.gov record(s).

Program details

Company
AEON Biopharma
Indication
Cervical Dystonia
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials